Preparing your pharmacy to deliver COVID-19 vaccinations: Tips from the front line - March 24, 2021 | 2:00-3:30 PM ET
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Preparing your pharmacy to deliver COVID-19
vaccinations: Tips from the front line
March 24, 2021 | 2:00-3:30 PM ET
Housekeeping and Technology Tips
• All attendees are on mute, by default
• Use the Q&A box to submit any questions for technical support or for our
speakers
• This is not an accredited session (no CEUs or Statements)
• This session will be recorded and a video of the session will be made
available at http://www.pharmacists.ca/webinars along with any other
session resources
• When the webinar is over, don’t close the window right away:
• An evaluation survey will pop up on your screen. Please complete this to
provide us with some feedback
2
COVID-19 Vaccines in Canada
Canada’s Vaccine Rollout Strategy
Vaccine distribution in Canada is occurring in stages, with priority individuals:
Stage 1 Stage 2 Stage 3
Adults 70+ Adults 60-69 Adults 50-59
Long-term care residents/staff Residents/staff of other shared People 16-59 with an underlying
living settings medical condition
Frontline health care workers First responders Non-frontline health care workers
Adults in Indigenous communities Adults in racialized/marginalized Non-frontline essential workers
communities
Frontline essential workers
Essential primary caregivers
Note: Individual jurisdictions hold the decision of final vaccine rollout plans and may differ from the one shown above.
The Government of Canada anticipates every eligible Canadian will be immunized by September 2021.
4 Government of Canada, 2021
COVID-19 Vaccines Procured for Canada
Sanofi and
Pfizer-BioNTech Moderna AstraZeneca Janssen Medicago Novavax
GlaxoSmithKline
Viral Vector Viral Vector Recombinant Recombinant
Type mRNA vaccine mRNA vaccine Virus-like particle
vaccine vaccine protein subunit protein subunit
Age Group
Ages 16+ Ages 18+ Ages 18+ Ages 18+ ~ ~ ~
Authorization
Efficacy 95% efficacy 94.1% efficacy 62% efficacy 66% efficacy ~ ~ ~
2 doses, 21 days 2 doses, 28 days 2 doses, 4-12 2 doses, 3 weeks 2 doses, 3 weeks 2 doses, 3 weeks
Schedule Single dose
apart* apart* weeks apart* apart apart apart
Dose 0.3mL 0.5mL 0.5mL 0.5mL ~ ~ ~
Primary Storage -80°C to -60°C** -25°C to -15°C +2°C to +8°C +2°C to +8°C +2°C to +8°C +2°C to +8°C +2°C to +8°C
Doses Procured Up to 76 million 44 million 20 million Up to 38 million Up to 76 million Up to 76 million Up to 72 million
Pending HC Pending HC Pending HC
Status Approved Approved Approved Approved
authorization authorization authorization
* May be extended to 16 weeks of receipt of the first dose. See NACI statement for full details.
** May be stored at -25°C to -15°C for up to two weeks. See NACI statement for full details.
Government of Canada, 2021
5 PHAC, 2021
Vaccine administration is increasing in Canada
140000
120000
100000
80000
60000
40000
20000
0
Dec-14 Dec-21 Dec-28 Jan-04 Jan-11 Jan-18 Jan-25 Feb-01 Feb-08 Feb-15 Feb-22 Mar-01 Mar-08 Mar-15
Number administered per day
Data from COVID19Tracker.ca
6Status of Vaccine Rollout in Canada
BC AB SK MB ON QC NB NS PEI NL YT NWT NU Canada
Received 631,160 528,845 150,755 193,760 1,780,135 1,050,355 93,455 119,110 21,925 66,470 51,400 48,600 37,500 4,773,470
Administered 490,022 459,856 139,827 133,687 1,553,040 944,793 61,106 58,036 16,779 46,053 32,350 32,074 17,997 4,007,393
(/received) (77.6%) (86.95%) (92.75%) (68.95%) (87.2%) (89.9%) (65.4%) (48.7%) (76.5%) (69.3%) (62.9%) (66.0%) (48.0%) (84.0%)
One Dose
7.829% 8.279% 9.225% 6.561% 8.510% 11.271% 6.257% 3.880% 6.991% 7.033% 51.574% 43.673% 29.487% 8.884%
(% pop)
Fully
630,704
Vaccinated 1.698% 2.153% 2.645% 3.135% 2.038% 0.000% 1.572% 2.064% 3.577% 1.805% 25.14% 27.64% 16.53%
(1.671%)
(% pop)
Updated March 22, 2021
Data from COVID19Tracker.ca | USask
7To begin in community Community pharmacy pharmacies in Phase 3 (May) involvement is confirmed, but no timeline has been provided
References • Government of Canada. Vaccines and treatments for COVID-19: Vaccine rollout. Accessed March 16, 2021 at https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/prevention-risks/covid-19-vaccine- treatment/vaccine-rollout.html#a4. • Government of Canada. Janssen COVID-19 vaccine: What you should know. Accessed March 16, 2021 at https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines- treatments/vaccines/janssen.html#a3. • Government of Canada. Procuring vaccines for COVID-19. Accessed March 16, 2021 at https://www.canada.ca/en/public-services- procurement/services/procuring-vaccines-covid19.html. • Public Health Agency of Canada. An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI). Recommendations on the use of COVID-19 Vaccines. Accessed March 16, 2021. • N. Little. COVID-19 Tracker Canada (2020), COVID19Tracker.ca .Accessed March 22, 2021 9
Our Featured
Speakers
Myla Bulych,
Pharmacy Association of Saskatchewan, SK
Colleen MacInnis,
TLC Pharmasave, NS
Aaron Lo,
London Drugs, AB
Kristen Watt,
Kristen’s Pharmacy, ON
10Thank you
You can also read
